C-reactive protein and hormone replacement therapy - Response

被引：0
|
作者：
Cushman, M [1 ]
Sakkinen, PA
Tracy, RP
Legault, C
Barrett-Connor, E
Stefanick, ML
Kessler, CM
Judd, HL
机构：
[1] Univ Vermont, Dept Med, Burlington, VT 05405 USA
[2] Univ Vermont, Dept Pathol, Burlington, VT USA
[3] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA
[4] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA USA
[5] Stanford Univ, Stanford Ctr Res Dis Prevent, Palo Alto, CA 94304 USA
[6] Georgetown Univ, Dept Med, Div Hematol Oncol, Washington, DC USA
[7] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA
来源：
CIRCULATION | 2000年 / 102卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E96 / E97
页数：2
相关论文
共 50 条
  • [21] Effect of hormone replacement therapy on tissue factor activity, C-reactive protein, and the tissue factor pathway inhibitor
    Koh, KK
    Ahn, JY
    Kim, DS
    Han, SH
    Shin, MS
    Ryu, WSE
    Park, GS
    Ahn, TH
    Choi, IS
    Shin, EK
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (03): : 371 - +
  • [22] Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?
    Bukowska, H
    Stanosz, S
    Zochowska, E
    Millo, B
    Sieja, K
    Chelstowski, K
    Naruszewicz, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (01): : 72 - 78
  • [23] THE C-REACTIVE PROTEIN IN INFLAMMATORY RESPONSE
    LAURENT, P
    NOUVELLE PRESSE MEDICALE, 1981, 10 (34): : 2817 - 2820
  • [24] Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study
    Bowden, DW
    Lohman, K
    Hsu, FC
    Langefeld, CD
    Carr, JJ
    Lenchik, L
    Wagenknecht, LE
    Freedman, BI
    Herrington, DM
    DIABETIC MEDICINE, 2006, 23 (07) : 763 - 767
  • [25] Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women
    Barinas-Mitchell, E
    Cushman, M
    Meilahn, EN
    Tracy, RP
    Kuller, LH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : 1094 - 1101
  • [26] Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein
    Herrington, DM
    Howard, TD
    Brosnihan, KB
    McDonnell, DP
    Li, XL
    Hawkins, GA
    Reboussin, DM
    Xu, JF
    Zheng, SQL
    Meyers, DA
    Bleecker, ER
    CIRCULATION, 2002, 105 (16) : 1879 - 1882
  • [27] Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
    van Baal, WM
    Kenemans, P
    van der Mooren, MJ
    Kessel, H
    Emeis, JJ
    Stehouwer, CDA
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (06) : 925 - 928
  • [28] The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial
    Walsh, BW
    Paul, S
    Wild, RA
    Dean, RA
    Tracy, RP
    Cox, DA
    Anderson, PW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01): : 214 - 218
  • [29] Hold, raise, or fold: C-reactive protein, hormone therapy, and cardiovascular risk
    Stuenkel, Cynthia A.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (01): : 8 - 10
  • [30] Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine
    Barnes, JF
    Farish, E
    Rankin, M
    Hart, DM
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (01): : 92 - 98
12345